NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic. - podcast episode cover

NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.

Mar 29, 20236 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.
For the best experience, listen in Metacast app for iOS or Android